Fred Elfman

691 total citations
21 papers, 600 citations indexed

About

Fred Elfman is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Fred Elfman has authored 21 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology and Allergy. Recurrent topics in Fred Elfman's work include Glycosylation and Glycoproteins Research (8 papers), Cell Adhesion Molecules Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Fred Elfman is often cited by papers focused on Glycosylation and Glycoproteins Research (8 papers), Cell Adhesion Molecules Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Fred Elfman collaborates with scholars based in United States, Germany and Japan. Fred Elfman's co-authors include H. Daniel Perez, R. Ebner, Rik Derynck, Bradley A. Arrick, C H Damsky, Dennis E. Chenoweth, Alfredo R. Lopez, Gerald R. Cunha, Shelley R. Marder and Edward J. Kelly and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Cell Biology and The Journal of Immunology.

In The Last Decade

Fred Elfman

21 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Elfman United States 14 328 141 141 125 114 21 600
Aysim Yilmaz Switzerland 5 301 0.9× 174 1.2× 170 1.2× 131 1.0× 125 1.1× 7 556
K Mafune Japan 14 367 1.1× 147 1.0× 86 0.6× 103 0.8× 79 0.7× 28 698
G Kamińska United States 9 267 0.8× 137 1.0× 91 0.6× 88 0.7× 151 1.3× 21 520
Carlos Rı́us Spain 12 473 1.4× 126 0.9× 79 0.6× 90 0.7× 75 0.7× 19 755
Renato G.S. Chirivi Italy 17 362 1.1× 208 1.5× 321 2.3× 91 0.7× 215 1.9× 28 791
H Uchino Japan 13 203 0.6× 134 1.0× 147 1.0× 113 0.9× 30 0.3× 22 527
Sal LaForgia United States 15 591 1.8× 153 1.1× 222 1.6× 161 1.3× 72 0.6× 20 941
Erich Weber Switzerland 10 418 1.3× 396 2.8× 174 1.2× 104 0.8× 85 0.7× 17 757
Chiyoko Sekine Japan 15 327 1.0× 125 0.9× 337 2.4× 67 0.5× 131 1.1× 17 754
Anette Knedla Germany 4 244 0.7× 140 1.0× 162 1.1× 100 0.8× 68 0.6× 5 650

Countries citing papers authored by Fred Elfman

Since Specialization
Citations

This map shows the geographic impact of Fred Elfman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Elfman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Elfman more than expected).

Fields of papers citing papers by Fred Elfman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Elfman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Elfman. The network helps show where Fred Elfman may publish in the future.

Co-authorship network of co-authors of Fred Elfman

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Elfman. A scholar is included among the top collaborators of Fred Elfman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Elfman. Fred Elfman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elfman, Fred, Robert Bok, Marion Conn, Marc Shuman, & Gerald R. Cunha. (2001). Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate. Differentiation. 69(2-3). 108–120. 5 indexed citations
2.
Sutherland, Ronald S., Laurence S. Baskin, Fred Elfman, Simon W. Hayward, & Gerald R. Cunha. (1997). The Role of Type IV Collagenases in Rat Bladder Development and Obstruction. Pediatric Research. 41(3). 430–434. 18 indexed citations
3.
Evans, Christopher P., Fred Elfman, Gerald R. Cunha, & Marc A. Shuman. (1997). Decreased prostate cancer cell migration by inhibition of the insulin-like growth factor II/Mannose-6-Phosphate receptor. Urologic Oncology Seminars and Original Investigations. 3(5-6). 166–170. 4 indexed citations
4.
Evans, Christopher P., Fred Elfman, Sareh Parangi, et al.. (1997). Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade.. PubMed. 57(16). 3594–9. 59 indexed citations
5.
Shima, Hiroki, Motomu Tsuji, Fred Elfman, & Gerald R. Cunha. (1995). Development of Male Urogenital Epithelia Elicited by Soluble Mesenchymal Factors. Journal of Andrology. 16(3). 233–241. 16 indexed citations
6.
Lim, Melissa, Fred Elfman, Austin Dohrman, Gerald R. Cunha, & Carol Basbaum. (1995). Upregulation of the 72-kDa Type IV Collagenase in Epithelial and Stromal Cells during Rat Tracheal Gland Morphogenesis. Developmental Biology. 171(2). 521–530. 17 indexed citations
7.
Arrick, Bradley A., Alfredo R. Lopez, Fred Elfman, et al.. (1992). Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1.. The Journal of Cell Biology. 118(3). 715–726. 145 indexed citations
8.
Demeure, Michael J., Caroline H. Damsky, Fred Elfman, et al.. (1992). Invasion by cultured human follicular thyroid cancer correlates with increasedβ1 integrins and production of proteases. World Journal of Surgery. 16(4). 770–776. 54 indexed citations
9.
Perez, H. Daniel, Edward J. Kelly, Fred Elfman, Gary C. Armitage, & James R. Winkler. (1991). Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis.. Journal of Clinical Investigation. 87(3). 971–976. 59 indexed citations
10.
Lobo, Errol, Fred Elfman, Edward J. Kelly, & H. Daniel Perez. (1990). Effect of phorbol myristate acetate on processing of formyl peptide receptors by human neutrophils. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1055(2). 193–196. 2 indexed citations
11.
12.
Kurrasch, Regina, Fred Elfman, & H. Daniel Perez. (1989). Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.. The Journal of Immunology. 143(6). 1969–1973. 3 indexed citations
13.
Perez, H. Daniel, Edward J. Kelly, Dennis E. Chenoweth, & Fred Elfman. (1988). Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).. Journal of Clinical Investigation. 82(1). 360–363. 60 indexed citations
14.
Perez, H. Daniel, et al.. (1988). Homology with Vitamin D-binding Protein (Group-specific Component Globulin). 4 indexed citations
15.
Perez, H. Daniel, Edward J. Kelly, Dennis E. Chenoweth, & Fred Elfman. (1988). Identification of the C5a des Arg cochemotaxin.. PubMed. 101. 242–9. 6 indexed citations
16.
Perez, H. Daniel, Fred Elfman, & Shelley R. Marder. (1987). Meclofenamate sodium monohydrate inhibits chemotactic factor–induced human polymorphonuclear leukocyte function. a possible explanation for its antiinflammatory effect. Arthritis & Rheumatism. 30(9). 1023–1031. 17 indexed citations
17.
18.
Perez, H. Daniel, Shelley R. Marder, Fred Elfman, & Harlan E. Ives. (1987). Human neutrophils contain subpopulations of specific granules exhibiting different sensitivities to changes in cytosolic free calcium. Biochemical and Biophysical Research Communications. 145(2). 976–981. 26 indexed citations
19.
20.
Perez, H. Daniel, et al.. (1985). Removal or oxidation of surface membrane sialic acid inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis.. The Journal of Immunology. 134(3). 1902–1908. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aysim Yilmaz Breakdown of academic impact, for papers by K Mafune Breakdown of academic impact, for papers by G Kamińska Breakdown of academic impact, for papers by Carlos Rı́us Breakdown of academic impact, for papers by Renato G.S. Chirivi Breakdown of academic impact, for papers by H Uchino Breakdown of academic impact, for papers by Sal LaForgia Breakdown of academic impact, for papers by Erich Weber Breakdown of academic impact, for papers by Chiyoko Sekine Breakdown of academic impact, for papers by Anette Knedla
Rankless by CCL
2026